Sakamoto Y, Oniki K, Kumagae N, Morita K, Otake K, Ogata Y, Saruwatari J.
Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals.
Dis Markers. 2019;2019:4065327

Nishimura F, Ushijima T, Mishima A, Sugino Y, Yanagi S, Miyamura S, Oniki K, Saruwatari J.
Risk factors associated with delirium after cardiovascular surgery and development of a check sheet to screen for postoperative delirium.
J Jpn Soc Intensive Care Med. 2019;26(6):438-444.

Maeda T, Oniki K, Miike T.
Sleep Education in Primary School Prevents Future School Refusal Behavior.
Pediatr Int. 2019;61(10):1036-1042.

Inaba I, Kondo Y, Iwasaki S, Tsuruhashi S, Akaishi A, Morita K, Oniki K, Saruwatari J, Ishitsuka Y, Irie T.
Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions.
Front Pharmacol. 2019; 10: 874.

Shimizu K and Oniki K.
Development of a Novel Method for the Treatment and Prevention of Diabetes Mellitus.
YAKUGAKU ZASSHI, 2019;139(1):39.

Oniki K and Saruwatari J.
A Multifaceted Approach regarding the Association of the DsbA-L Gene with the Risk of Obesity-related Diseases Based on Clinical Pharmacogenetics.
YAKUGAKU ZASSHI, 2019;139(1):53-60.